Correlation Between Dominari Holdings and United Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and United Therapeutics, you can compare the effects of market volatilities on Dominari Holdings and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and United Therapeutics.
Diversification Opportunities for Dominari Holdings and United Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dominari and United is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and United Therapeutics go up and down completely randomly.
Pair Corralation between Dominari Holdings and United Therapeutics
Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the United Therapeutics. In addition to that, Dominari Holdings is 1.36 times more volatile than United Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. United Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 34,971 in United Therapeutics on August 28, 2024 and sell it today you would earn a total of 1,895 from holding United Therapeutics or generate 5.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dominari Holdings vs. United Therapeutics
Performance |
| Timeline |
| Dominari Holdings |
| United Therapeutics |
Dominari Holdings and United Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dominari Holdings and United Therapeutics
The main advantage of trading using opposite Dominari Holdings and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.| Dominari Holdings vs. CytomX Therapeutics | Dominari Holdings vs. Instil Bio | Dominari Holdings vs. Spero Therapeutics | Dominari Holdings vs. Assembly Biosciences |
| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |